News & Events

A&W Restaurants’ Growth Trajectory

LEXINGTON, Ky. (Dec. 19, 2017) A&W Restaurants, Inc., a Lexington-based restaurant group with nearly 1,000 locations in the U.S. and Southeast Asia, looks to double down on restaurant growth in 2018 heading into its 100th Anniversary in 2019.  A&W recently celebrated the 6th Anniversary of their divestiture from Yum! Brands by announcing the brand’s core business is up nearly 30% over this timespan, and recent investments in new unit development look to increase those numbers in the foreseeable future.  The brand has seen many successful product launches since 2011, including the launch of Hand-Breaded Chicken Tenders in 2013, which stemmed from the major restaurant industry trend towards boneless chicken.  In addition to new product launches centered on quality positioning, A&W has focused on a return to Local Store Marketing and developing tools for restaurant operators to advertise in their own communities.  And as of May 2017, one-hundred percent of all A&W restaurants now make their signature Root Beer fresh in each of their restaurants, with the same recipe that made the brand famous.
Photo of Kevin Bazner, president and CEO of A&W Restaurants, Inc.One of A&W’s major growth initiatives over the last few years has been a return to actively franchising the brand and building new units, something that was not emphasized during the first few years as a new company.  “For the first few years after leaving Yum! Brands, our focus was on strengthening the existing system.  We were not focused on building new restaurants,” Kevin Bazner, president and CEO explains. “We started getting requests to build from our franchisees in 2014 and in 2015 began actively franchising again.  Our goal this year was to build 15 new restaurants, and we hit that mark.  Next year we are shooting for 20.”  Bazner says A&W is going into markets where there used to be A&Ws, but they may have long closed down.  “The exciting part of this turnaround is being able to go back and build in smaller communities where there are so many fond memories of A&W.  We are definitely seeing increased demand to build in small-town America.”
When asked if being based in Lexington has impacted A&W’s overall business objectives and its team of approximately 30 Lexington-based employees, Bazner confirmed yes.  “The talent in central Kentucky is outstanding, and therefore we have not had to recruit outside of the region.  The cost of living is low, we are able to pay very competitive rates, and the strong arts and restaurant culture of Lexington continues to be a bonus for all those who live here.”  Bazner says the four company-owned restaurants in the Lexington market continue to do well, and A&W is looking at ways to expand the learnings that have come from their corporate stores into the other restaurants around the country.  “We are thankful to the Lexington community for allowing us to grow in the community.  We’ve been a quiet neighbor but you’ll be seeing much more of us in the coming years.”

Coldstream Research Park Could Get Townhomes, Retail, Restaurants

Changes to Fayette County’s zoning ordinances — to allow the University of Kentucky’s Coldstream Research Park to add apartments, townhomes or condos to the 735-acre park — received first approval Thursday, March 23.
The Urban County Planning Commission voted unanimously to change the zoning ordinance to allow the research park to use as much as 15 percent of its land for multifamily housing or retail, apartments or townhomes. Some of the other changes include allowing for more density by requiring less greenspace around buildings and increasing allowed building heights.
The park off Newtown Pike on the north side of Lexington already is allowed to have some retail and hotels. The multi-family residences would be new.
Those changes to what is allowed in the office, industrial, research park, or P-2, zone now goes to Urban County Council for final approval.
Coldstream is the only property in Lexington zoned P-2, and the designation will be changed to “university research campus” instead of “office, industrial, research park zone.”
UK Coldstream Research Park officials have said that adding residential units will allow it to attract more businesses to the research park. Isolated industrial and research parks are outdated. People want to live, work and shop in the same area, UK officials have said.
The 2009 UK Coldstream Research Park master plan recommended adding apartments or other multifamily units. Coldstream Research Park has struggled to attract businesses. UK has pondered making changes to the P-2 zone for nearly a decade.
“Multifamily housing will allow for the creation of a dynamic-live-work-play-learn environment to provide the social infrastructure necessary to drive the development of office and R&D (research and development) facilities,” wrote George Ward, executive director of Coldstream Research Park, in his October application for the P-2 zone text changes.
“This is about a better, more efficient research park,” said Nick Nicholson, a lawyer who represents Coldstream. The current lot size is five acres, but only 25 percent of it can be used for buildings, Nicholson said. “You have greenspace around buildings that is not usable and is not pedestrian-friendly.”
By decreasing some of those requirements, the park can add apartments and restaurants, and can increase the amount of land available for job creation, he said.
“We are doubling employment square footage,” Nicholson said. “Smaller parcels also make it more affordable.”
Those restaurants, hotels or apartments will be in the interior of the park, Nicholson said.
Currently, there is only one restaurant in the park, which houses 56 companies or organizations. About 2,300 people work there. There was no opposition to the changes to the P-2 zone during Thursday’s planning commission hearing. The Fayette Alliance, a nonprofit that advocates on land use, supported the change.

UK Veterinary Diagnostic Lab Director Wins International Prize

LEXINGTON, Ky. (Aug. 30, 2017) — The University of Kentucky’s Craig Carter is a recognized leader in veterinary medicine around the world. Recently the American Veterinary Medical Association presented the 2016 International Veterinary Congress Prize to Carter, director of the Veterinary Diagnostic Lab located on UK's Coldstream Research Campus. The prize recognizes his international contributions to veterinary health.
“Throughout his career, Dr. Carter has displayed a strong commitment to improving international understanding of veterinary medicine,” said Joe Kinnarney, AVMA president. “He is a service-oriented individual whose contributions to One Health efforts have had far-reaching effects across the globe. I congratulate him on this award, and thank him for his many years of dedication to international veterinary medicine and tireless efforts to improve public health in the United States and around the world.”
“This is a great and exceedingly humbling honor that I accept on behalf of so many contributing to international veterinary medicine,” Carter said.
Carter earned a doctorate in veterinary medicine, a master’s degree in epidemiology and a doctorate of philosophy in veterinary public health from Texas A&M University. UK recruited Carter to the College of Agriculture, Food and Environment in 2005 to build an epidemiology program that would provide for the early detection of animal disease outbreaks such as Mare Reproductive Loss Syndrome. In 2007, he was appointed to his current position as director of UK Veterinary Diagnostic Laboratory where he oversees lab operations, conducts research and works with graduate students.
He also is on faculty at the UK College of Public Health and at the Lincoln Memorial University College of Veterinary Medicine in Harrogate, Tennessee. Carter’s military career spanned four decades, starting with active duty and then reserves in the U.S. Air Force and later in the U.S. Army Reserve, from which he retired as a colonel in 2009.
Upon his retirement, Carter received the Army Medical Reserve Legion of Merit for service throughout his 30-year career as veterinary readiness adviser for the U.S. Army Reserve Medical Command. He also received the Joint Service Commendation Medal for service as senior veterinarian in Task Force Ramadi, Iraq, in 2008. He received the Bronze Star in 2002 for commanding the first U.S. Army veterinary reserve unit deployed to Afghanistan after 9/11.
Carter has been very engaged internationally as a consultant to the Department of Defense, U.S. Department of Agriculture Foreign Agricultural Service (USDA FAS), the World Organization for Animal Health and the U.S. Agency for International Development. He recently traveled to Vietnam, Iraq, Kuwait, Qatar, Bahrain, Jordan, China, Thailand, Australia, Uruguay, Nicaragua and Ethiopia, where he evaluated diagnostic laboratories, delivered lectures and participated in nation-building activities. In 2009, he participated in a USDA FAS mission to Afghanistan to advise the Afghanistan Ministries of Agriculture and Public Health on strategic planning for veterinary diagnostic laboratories, animal disease monitoring and surveillance and public health. Since 1999 as executive director of the World Association of Veterinary Laboratory Diagnosticians, he has coordinated and helped to plan eight international meetings in various countries to advance the field of diagnostic veterinary medicine around the world.
Earlier this year, Carter took the helm of the American Veterinary Epidemiology Society as president for a five-year term.

Piramal Pharma Solutions Expands Capacity for Sterile Manufacturing in Lexington

LEXINGTON, Ky. (Aug. 18, 2016) Piramal Pharma Solutions, a provider of sterile drug product development and manufacturing services, has announced plans for a $25 million expansion of its facilities located on the Coldstream Research Campus in Lexington, Kentucky.
Piramal Pharma Solutions’ plan focuses on expanding the Lexington site capabilities and capacity for commercial aseptic manufacturing. This will be done by increasing vial filling capability and lyophilisation capacity, as well as upgrades to the associated facilities and utilities. Piramal’s Lexington site has a strong pipeline of products which are expected to be commercialized in next 3 to 5 years. Add to that the fast growing Sterile Market in the US, recent consolidations in the CMO space and shut down of many manufacturing sites in the US, has created a big demand for quality manufacturers in the Sterile segment. The Sterile market in the US and Europe is growing at a healthy rate of 11% and the Contract Manufacturing in the Sterile Dosage Form is growing at 13% year on year. Piramal believes that it can take advantage of the market situation and grow it Lexington business multi-fold.
Phase 1 of the expansion of the Lexington facility will add a new manufacturing suite including a high speed vial filling machine that provides controlled/safe environment for handling potent materials with an advantage of automated Vial Washing and Sterilization. Also as part of the first phase of expansion, Piramal will install a new isolator based vial filler in its existing manufacturing suite, which is a newer technology and considered much higher in quality standards. Combined, the two fillers installed under Phase I of the expansion will increase the company’s vial filling capabilities by more than five-fold. Phase 2 of the expansion will include the installation of two state-of-the-art lyophilizers and are planned to integrate with the new filler line in the new manufacturing suite offering dedicated capacity for both potent and non-potent products
Vivek Sharma, CEO – Pharma Solutions, Piramal Enterprises, commented: “Since our initial investment the Kentucky site has demonstrated both leadership and growth, and we are pleased to announce this next phase of investment to enhance capability and capacity. We appreciate the active support from the State of Kentucky, the local Government, and most importantly, the community, as we continue our growth plans in Lexington. The expansion in our capacity at Kentucky will help us better serve our customers who are looking for us to deliver solutions that will improve the standard of care.”
Bill Wedlake, President of Piramal Pharma Solutions Formulations Business added, “We are extremely excited to initiate this expansion and continue the company’s vision of becoming the premier aseptic manufacturing service provider that began with the acquisition of Coldstream Laboratories in January of 2015.”
About Piramal Pharma Solutions
Piramal Pharma Solutions, the Contract Development and Manufacturing arm of Piramal Enterprises Ltd., has assets across North America, Europe and Asia and offers services across the entire drug lifecycle – from development and commercial manufacturing to off-patent supplies of API and formulations. In 2015, the division acquired Coldstream Laboratories in Kentucky, a Contract Development and Manufacturing Organization focused on the development and manufacturing of sterile injectable products. This facility is a specialty pharmaceutical contract manufacturing organization, also offering full analytical, and formulation, microbiology, and lyophilization development services. Piramal Pharma Solutions at Kentucky specializes in the development and manufacture of highly potent compounds and operates as Kentucky’s only parenteral manufacturing facility.
About Piramal Enterprises Limited
Piramal Enterprises Limited (PEL) is one of India’s large diversified companies, with a presence in Healthcare, Healthcare Information Management and Financial Services. PEL’s consolidated revenues were around $ 1 billion in FY2016, with 61% of revenues from outside India.
PEL is listed on the Bombay Stock Exchange and the National Stock Exchange in India.
For more information, visit or email

UK Police Hosting Regional K-9 Certification and Trials

LEXINGTON, Ky., (July 8, 2016) — The University of Kentucky Police Department is hosting the United States Police Canine Association Region 5 Certification and Trials event beginning this Sunday July, 10, and continuing through Wednesday, July 13, at the Carnahan House in Lexington.
“Law enforcement canines serve an invaluable function both to their agencies and to the community they serve,” UKPD Chief Joe Monroe said. “We are honored to host the USPCA Region 5 Certification and Trials event this year.”
The United States Police Canine Association is the largest and oldest active organization of its kind. Region 5 encompasses law enforcement canine agencies across Kentucky, Ohio and Indiana. These canines will be seeking recertification in agility, obedience, tracking, criminal apprehension, article evidence, narcotics detection and explosives detection at the historic Carnahan House, located on UK's Coldstream Research Campus, just off Newtown Pike.
“Regional and national certification for canine law enforcement agencies are an important tool in standardizing the level of expertise these canines and their handlers must have to become credible witnesses in their respective fields,” said USPCA Region 5 President Jason Thomas.
In 2004, UKPD obtained its first canine as a result of a mutual aid agreement with the Bureau of Alcohol, Tobacco, Firearms and Explosives. The K-9 unit has grown to three canines — their names are Pink, Baska and Junior.
Members of the public are invited to attend the outdoor testing of law enforcement canines including the agility, obedience and criminal apprehension trials on Tuesday, July 12, and Wednesday, July 13.
For more information about USPCA, visit
For more information about the Region 5 Certification and Trials, visit

Dr. Shepard-Jones Appointed Director of UK's Human Development Institute

LEXINGTON, Ky. (Feb. 25, 2016) —The University of Kentucky Office of the Vice President for Research has appointed Kathleen Sheppard-Jones as the new director of the Human Development Institute (HDI), a University Center for Excellence in Developmental Disabilities (UCEDD) at UK. 

Sheppard-Jones received her doctoral degree in educational psychology from UK in 2002 and has worked with HDI since 1996. She previously served as training director for the institute. In that role, she built relationships with faculty and staff across colleges at UK and beyond. In addition to her director responsibilities, Sheppard-Jones is also principal investigator across a variety of grants and contracts around quality supports for people through the lifespan. She is currently an adjunct professor in the Department of Early Childhood, Special Education and Rehabilitation Counseling.
”HDI promotes the inclusion, independence and contributions of people with disabilities across the lifespan," said Vice President for Research Lisa A. Cassis. "As one of 67 UCEDD programs across the nation, this mission is accomplished through research, education, information sharing, leadership and advocacy — across the Commonwealth and the nation. With 45 projects and over 200 staff, Dr. Sheppard-Jones’ background and experience building interdisciplinary collaboration will ensure HDI is part of the research agenda that improves life outcomes for all Kentuckians and particularly addresses disparities for those with disabilities.”
“I’m extremely honored to be HDI’s executive director," Sheppard-Jones said."We have huge challenges ahead of us, but I cannot imagine a better team of dedicated and innovative professionals, self-advocates and families with whom to share this journey. Together, we will forge ahead to promote a society that is inclusive for all, and help to erase health disparities for Kentuckians with disabilities. The University of Kentucky is an environment that will enable us to conduct state of the art translational research, provide training to interdisciplinary students who will be the leaders of tomorrow, and collaborate with communities to demonstrate service models that result in meaningful life outcomes.”

Lannett Company, Summit Biosciences Receives FDA Approval for Sumatriptan

LEXINGTON, Ky. (Feb. 22, 2016)  Lannett Company, Inc. announced today that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray USP, 5 mg/spray and 20 mg/spray, the therapeutic equivalent to the reference listed drug Imitrex® Nasal Spray, of GlaxoSmithKline. According to IMS, total U.S. sales in 2015 of Sumatriptan Nasal Spray USP, 5 mg/spray and 20 mg/spray at Average Wholesale Price (AWP) were approximately $62 million. 

"We believe our Sumatriptan Nasal Spray USP, 5 mg/spray and 20 mg/spray will be a first-to-market generic product," said Arthur Bedrosian, chief executive officer of Lannett. "Producing nasal delivery medications requires unique expertise and facilities that few possess. Our Sumatriptan Nasal Spray product was developed by Summit Biosciences Inc. and will be manufactured at its state-of-the-art facility located on the University of Kentucky's Coldstream Research Campus. We expect to commence marketing the product in the next several months."

About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. For more information, visit the company's website at

About Summit Biosciences Inc.:
Summit Biosciences, founded in 2009, is a specialty pharmaceutical company focused on developing and commercializing generic and innovative nasal drug products. For more information, visit the company's website at

Craig Carter Named President of American Veterinary Epidemiology Society

Craig Carter

LEXINGTON, Ky. (Feb. 11, 2016) — Craig N. Carter, director and professor of epidemiology at the University of Kentucky Veterinary Diagnostic Laboratory (UKVDL), recently took the helm of the American Veterinary Epidemiology Society (AVES) as president for a five-year term. 
AVES was founded by James H. Steele in 1964 to recognize global leaders in infectious disease epidemiology and public health and to foster research to combat infectious diseases in both animals and humans. The society has recognized more than 70 world-renowned scientists through awarding the K.F. Meyer/James H. Steele Gold Headed Cane Award, which Carter received in 2011, primarily for his work on zoonotic diseases.
“I consider it such a great honor and privilege to serve as the president of the American Veterinary Epidemiology Society for the next five years," said Carter. "Since leaving my ambulatory practice in Texas, I have worked as an epidemiologist in service, research and teaching roles in the university, military and international consulting environments for over thirty years. Dr. Jim Steele — founder of the AVES and the CDC division of epidemiology — was my graduate professor, mentor and dear friend for many years until his death at 100 years young in 2013."
Carter was recruited from Texas A&M University to the UK College of Agriculture, Food, and Environment in 2005 to build an epidemiology program to provide for the early detection of animal disease outbreaks such as Mare Reproductive Loss Syndrome. In 2007, he was appointed to his current position at UKVDL where he oversees lab operations, conducts research and works with his graduate students.
One of Carter’s goals for the AVES is to attract more bright students into careers in epidemiology. Sponsored by Hartz Mountain Corporation, the AVES hosts its annual meeting each year as part of the American Veterinary Medical Association (AVMA) meeting.  The 2016 meeting will be held in July, in San Antonio, Texas. A celebration of the 100th anniversary of the U.S. Army Veterinary Corps will also be held at Fort Sam Houston in San Antonio in conjunction with the AVMA meeting. Carter’s military career spanned from 1967-2008, retiring as a full colonel in the U.S. Army Reserve Veterinary Corps. 
Carter said he has thoroughly enjoyed his many years as a faculty member at UK.
"Now nearing the end of my career, I delight in this opportunity to give something back to the AVES and to a scientific discipline that has been so good to me and the world.”

Piramal Pharma Solutions to invest $10M, add 40 jobs at Coldstream Laboratories

LEXINGTON, Ky. (Feb. 3, 2016) — Coldstream Laboratories, a pharmaceutical manufacturer now owned by Piramal Pharma Solutions, is planning a $10 million expansion that will add 40 jobs at their Coldstream Research Campus location in Lexington, KY.
Piramal Pharma Solutions plans to invest up to $10 million to expand operations at Lexington’s Coldstream Laboratories Inc., creating 40 new jobs, Gov. Matt Bevin and Lexington Mayor Jim Gray announced today. The India-owned company last year purchased Coldstream Labs, which develops and manufactures injectable pharmaceuticals.
“Growth in private-sector employment—particularly high-paying, skilled jobs like these—moves Kentucky forward on the national and global level,” Bevin said. “On behalf of all Kentuckians, I congratulate and thank Piramal Pharma Solutions and Coldstream for this investment to further strengthen Kentucky’s pharmaceutical industry. We are excited by this opportunity to become an increasingly important part of Piramal’s global footprint and look forward to many years of partnership with them.”
Coldstream Labs started in 1991 as the Center for Pharmaceutical Science & Technology, a unit of the University of Kentucky College of Pharmacy. It completed more than 200 development projects that led to clinical trials. In 2007, the college spun off Coldstream Labs as a private company owned by the University of Kentucky Research Foundation.
As a separate independent business, Coldstream Labs gained the ability and technical expertise to manufacture liquid and freeze-dried injectable products. In January 2015, the Research Foundation sold Coldstream Labs to Piramal Pharma Solutions., a global leader in pharmaceutical contract services, and the flagship division of the Mumbai, India-based Piramal Group. Under Piramal, Coldstream Labs can access the financial resources needed to expand its facilities and meet its customers’ needs.
“The excellence of the University of Kentucky Pharmacy program and the brainpower it has brought to Lexington are creating good jobs for our citizens,” Gray said. “These are homegrown jobs that build on our growing reputation in the pharmaceutical industry.”
The Piramal Group operates in more than 30 countries with a presence in 100-plus markets around the world. Piramal Pharma Solutions, a division of Piramal’s flagship company Piramal Enterprises Limited, also maintains U.S. operations in Bethlehem, Pa. in addition to Coldstream Labs.
To encourage the investment and job growth in Lexington, the Kentucky Economic Development Finance Authority (KEDFA) preliminarily approved the company for tax incentives up to $800,000 through the Kentucky Business Investment program. The performance-based incentive allows a company to keep a portion of its investment over the agreement term through corporate income tax credits and wage assessments by meeting job and investment targets.
Additionally, KEDFA gave Coldstream Labs preliminary approval for up to $140,000 in tax incentives through the Kentucky Enterprise Initiative Act (KEIA). KEIA allows approved companies to recoup Kentucky sales and use tax on construction costs, building fixtures, equipment used in research and development and electronic processing.
Coldstream Labs can receive resources from the Kentucky Skills Network. Through the Kentucky Skills Network, companies are eligible to receive no-cost recruitment and job placement services, reduced-cost customized training and job training incentives. Last year, the Kentucky Skills Network trained more than 84,000 employees from more than 5,600 Kentucky companies.

Proposed Water Tank on Legacy Trail to Include Restrooms, Tees, Bike Racks

LEXINGTON, Ky. (Dec. 17, 2015) — The city of Lexington plans to spend $1.75 million to build restrooms and add trees and other amenities around a 70-foot-tall water storage tank to be built on the popular Legacy Trail on the Coldstream Research Campus by the end of December 2016.


The Fayette Urban-County Council recently approved the revamped plans for the new rest area. The tank — to be five stories tall and 200 feet in diameter — must be operational by the end of 2016.


As part of a $590 million overhaul of the city’s sanitary-sewer and storm-sewer systems, the city must install a “wet weather” storage tank near the Cane Run pump station. That pump station is at the back of the Coldstream Research Campus, off Newtown Pike on the Legacy Trail. The tanks are used to store water during heavy rain, helping to decrease the number of storm water overflows.


Charlie Martin, the city’s director of water quality, appeared before the council in September with a preliminary design. The designs unveiled Tuesday were altered slightly but contain the same design elements — a rest room, shade trees, bike racks, a water fountain and other amenities. The Legacy Trail currently has little shade and no restrooms.


Martin has met with stakeholders — including tenants of the Coldstream Research Campus, the Blue Grass Community Foundation, the Lexington Art League and others — for nearly a year to discuss ideas to make the are around the tank a rest area and not an eyesore.

Syndicate content